Reinventing Pharma’s Talent Search

In this ISSUE

Q&A: Hugh McTavish, CEO, Squarex and IGF-Oncology

Q&A: Seth Lederman, CEO, Tonix Pharmaceuticals

Reducing Barriers to Great Patient Care and Supporting Product Success

Talent

Reinventing Pharma's Talent Search

Thinning talent pools, combined with evolving industry trends and job-seeker motivations, are testing traditional pharma hiring methods, where targeting new skills and capabilities must become the new norm
… /Read more/

Advertisement
	Deloitte's 2019 Life Sciences accounting and financial reporting update Insights on new accounting standards and more A year of major change for life sciences companies is underway. Deloitte's latest update on life sciences financial reporting explains what accounting departments need to know to keep up in a rapidly evolving environment. Download the full report here

Talent

Succession Planning: It's Not Just for Human Resources

Teams and organizations that rely solely on the HR function for succession planning are doing themselves a disservice, write Joy Taylor and Kim Lehman
… /Read more/

Talent

Empowering Women Entrepreneurs in Healthcare

The significant scale that is necessary to break into the healthcare marketplace poses the greatest barrier to entry for women entrepreneurs. Shaleta Dunn outlines strategies that aspiring businesswomen can adopt to foster their success
… /Read more/

Patient Adherence: A Hard Pill to Swallow?
On Demand

Learn More

Talent

Skills Shortage: An Imminent Threat to Life Sciences Innovation

Industry needs to realize the potential that new treatments and technologies hold and put skills at the top of its collective agenda, write Ian Marison and Peter Levison
… /Read More/

Using Real-World Evidence for U.S. Regulatory Decision-Making: What Pharma Needs to Know
On Demand

Learn More

Regulatory

FDA Moves to Modernize Drug Review Process

A new CDER "knowledge management" approach will see companies submit applications that can be transmitted to experts from multiple disciplines able to assess applications for new drugs and biologics in a timely and efficient manner
… /Read More/

Japan Market Entry: How to Navigate the Clinical Development Regulatory Environment and Best Methods to Utilize Opportunities
On Demand

Learn More

The Pharm Exec Podcast: J&J's World Without Disease Accelerator

Pharm Exec talks to Ben Wiegand, head of Johnson & Johnson's World Without Disease Accelerator, about J&J's disease prevention and interception activities
… /Click here to listen/

Calendar

/ May 15: MDR Workshop: Transitioning to the EU MDR and Managing Legacy Devices /

Brussels, Belgium

/ May 20–22: 21^st Medicaid and Government Pricing Congress /

Orlando, FL

/ May 30–31: Pharmaceutical Research &Innovations in Pharma Industry /

Orlando, FL

/ June 3–6: BIO International Convention /

Philadelphia, PA

/ June 12–13: Rare Disease Innovation and Partnering Summit /

Boston, MA

/ June 14–15: 13^th World Drug Delivery Summit /

Montreal, Canada

/ June 23–27: DIA 2019 /

San Diego, CA

Industry update

//Adhera Therapeutics (Research Triangle Park, NC) announced that its Board of Directors has appointed Nancy R. Phelan to serve as chief executive officer. // AMAG Pharmaceuticals (Waltham, MA) announced the appointment of Nancy Griffith, Ph.D., as vice president, scientific communications and medical operations. // GW Pharmaceuticals (Carlsbad, CA) appointed Darren Cline as its new US chief commercial officer. // Johan van Hylckama Vlieg, Ph.D., was named chief scientific officer and Clare Fisher was appointed chief business officer of Kaleido Biosciences (Lexington, MA). // PureTech Health (Boston, MA) appointed Santosh Shanbhag as chief financial officer and Jacqueline Studer as senior vice president and general counsel. // Surrozen (South San Francisco, CA) announced the appointment of Trudy Vanhove, M.D, Ph.D, MBA, as chief medical officer.

advertise with us / print subscribe / digital subscribe / visit pharmexec.com